Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Division of Preventive Oncology

Dr. Petra Schrotz-King (in ch.)

Dr. Petra Schrotz-King, previously head of the Colorectal Cancer Prevention Working Group, has been acting head of the Preventive Oncology Division since July 15, 2023. Under her leadership, the research program in the field of secondary prevention with a focus on innovative methods of early cancer detection and cancer prevention is currently being continued: the GEKKO study launched in 1-2016 as part of the NCT 3.0 program, the DARIO study (start 09/2016, study end 06/2020) and the LEO study recruiting since 12-2020, the latter with participants in the age group 30-49 as part of the NCT "Proof of Concept Trial" program.
The GEKKO study collaborates with numerous clinics and practices in the area, the LEO study is conducted in collaboration with the Interdisciplinary Endoscopy Center (IEZ) at the Medical Clinic of Heidelberg University Hospital.
Another focus of the division is risk-adapted prevention, a working group headed by Prof. Mahdi Fallah.


Dr. Petra Schrotz-King (in ch.)
Preventive Oncology (C120)
Deutsches Krebsforschungszentrum
und Nationales Centrum für Tumorerkrankungen (NCT)
Im Neuenheimer Feld 460
69120 Heidelberg
Tel: +49 6221 56-35970


Selected Publications

  • Raut J.R. et al (2021). A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction. Nat Commun. 12(1), 4811.
  • Tian Y. et al. (2019). Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study. BMJ 364:l803.
  • Gies A. et al. (2018) Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening. Gastroenterology 154(1):93-104.
  • Brenner H. et al. (2014). Colorectal cancer. Lancet, 383(9927), 1490-1502.
to top
powered by webEdition CMS